CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 132 filers reported holding CTI BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $295 | -99.9% | 49,149 | -4.9% | 0.00% | 0.0% |
| Q3 2022 | $301,000 | -51.4% | 51,704 | -50.2% | 0.00% | -42.9% |
| Q2 2022 | $619,000 | +1189.6% | 103,723 | +84.8% | 0.01% | – |
| Q2 2019 | $48,000 | +26.3% | 56,132 | +44.0% | 0.00% | – |
| Q1 2019 | $38,000 | +8.6% | 38,969 | -17.4% | 0.00% | – |
| Q4 2018 | $35,000 | – | 47,206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|